Insider Transactions Reported by 38 Insiders of Verve Therapeutics, Inc.

Location
Boston, MA

Insiders trading volume in the past year

Verve Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
GV 2019 GP, L.L.C. 10%+ Owner $44,725,090 21 Jun 2021
ARCH Venture Partners X, LLC 10%+ Owner $25,088,090 21 Jun 2021
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10%+ Owner $24,955,710 21 Jun 2021
Casdin Partners Master Fund, L.P. 10%+ Owner $24,175,960 21 Jun 2021
Redmile Group, LLC 10%+ Owner $19,365,300 21 Jun 2021
GV 2023 GP, L.L.C. Member of 10% Group $18,000,000 01 Dec 2023
Cormorant Asset Management, LP Former 10% Owner $9,842,240 21 Jun 2021
Logos Global Management LP 10%+ Owner $8,132,650 21 Jun 2021
Broad Institute, Inc. 10%+ Owner $8,097,840 21 Jun 2021
Novo Holdings A/S 10%+ Owner $7,932,650 21 Jun 2021
Casdin Private Growth Equity Fund, L.P. 10%+ Owner $6,205,710 21 Jun 2021
FMR LLC Other* $5,707,290 26 Jul 2022
Beam Therapeutics Inc. 10%+ Owner $5,469,700 21 Jun 2021
Israel Rozen 10%+ Owner $4,096,260 16 Jun 2021
Barry Ticho 10%+ Owner $4,096,260 16 Jun 2021
Jae Keith Joung 10%+ Owner $4,096,250 16 Jun 2021
Rock Springs Capital Management LP 10%+ Owner $1,529,260 21 Jun 2021
Andrew Bellinger Chief Scientific Officer $450,000 14 Feb 2024
Sekar Kathiresan Chief Executive Officer, Director $410,850 -$40,761 -9% 25 Jul 2025
Fred T. Fiedorek Chief Medical Officer $220,000 14 Feb 2024
Allison Dorval Chief Financial Officer $140,063 -$13,903 -9% 25 Jul 2025
Andrew Ashe President, Chief Operating Officer and General Counsel $112,050 -$11,126 -9% 25 Jul 2025
Joan Nickerson Chief Administrative Officer $74,700 -$11,525 -13% 25 Jul 2025
Jason Politi Chief Technical Ops. Off. $68,475 -$13,425 -16% 25 Jul 2025
Troy Lister Chief Scientific Officer $68,103 -$9,084 -12% 25 Jul 2025
Margaret Beaudoin Vice President, Finance $10,000 17 Jun 2021
ADELMAN BURT A Director $0 25 Jul 2025
GV 2017 GP, L.L.C. 10%+ Owner $0 25 Jul 2025
Krishna Yeshwant Director, 10%+ Owner $0 25 Jul 2025
Sheila Mikhail Director 25 Jul 2025
John M. Evans Director 09 Jun 2022
Alexander Cumbo Director 25 Jul 2025
ARCH Venture Fund X, L.P. 10%+ Owner 16 Jun 2021
Michael F. MacLean Director 25 Jul 2025
LONNEL COATS Director 25 Jul 2025
Jodie Pope Morrison Director 25 Jul 2025
Ourania Tatsis Director 25 Jul 2025
Biomatics Capital Partners, L.P. 10%+ Owner 16 Jun 2021

Recent Insider Transactions by Companies or Individuals for Verve Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.